Clinical Trial Update: Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing loss of response between an adalimumab biosimilar and the original adalimumab in Crohn's disease and ulcerative colitis has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Adalimumab biosimilar (adalimumab)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Crohn Disease, Ulcerative Colitis | Phase 4 | Status: TERMINATED